SCHEMBL22154709

SCHEMBL22154709

C#CCCCCN(C(=O)[C@@H](N=[N+]=[N-])[C@@H](C)CC)[C@H](C[C@@H](O[Si](C)(C)C(C)(C)C)c1nc(C(=O)OC)cs1)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28627175 1.00
SCHEMBL31232797 0.92
SCHEMBL24140468 0.85 ABCB1 (0.35)
SCHEMBL30360070 0.85 ABCB1 (0.35)
SCHEMBL28634045 0.83 ABCB1 (0.33)
SCHEMBL22154599 0.83 ABCB1 (0.33)
SCHEMBL28923611 0.82 ABCB1 (0.36)
SCHEMBL28923615 0.82 ABCB1 (0.36)
SCHEMBL30716467 0.81 ABCB1 (0.31)
SCHEMBL25827016 0.81 ABCB1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12144864-B2 Tubulysins and protein-tubulysin conjugates REGENERON PHARMACEUTICALS, INC. (US) 2024-11-19 US disclosed
CN-113454097-A Tubulysins and protein-tubulysin conjugates 里珍纳龙药品有限公司 2021-09-28 CN disclosed
WO-2020132658-A2 TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES REGENERON PHARMACEUTICALS, INC. (US) 2020-06-25 WO disclosed